Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries posted a 386% leap in its net profits, registering EGP 25.37 million in the first nine months of fiscal year (FY) 2020/2021, compared to EGP 5.22 million in the year-ago period, the unaudited financial results showed.
The company’s revenues increased by 4.6% to EGP 395.5 million from July 2020 until the end of last March, compared to EGP 378.3 million in the corresponding period a year earlier, according to a bourse disclosure on Wednesday.
During the first eight months of FY20/21, the company reported net profits before taxes of EGP 23.73 million, up from EGP 4.09 million in the prior-year period.
